The phospholipase A2 enzymes are important components of the cellular
machinery that responds to inflammatory stimuli and maintains cell hom
eostasis by membrane remodelling. Their role as the rate-limiting step
in the production of pro-inflammatory lipid mediators makes these enz
ymes an important therapeutic target for the treatment of inflammatory
disorders. Keith Glaser and colleagues explain how the two major grou
ps of phospholipase A2, the secretory and cytosolic forms, are very di
fferent both structurally and enzymatically. Understanding the relativ
e contributions of these different forms of phospholipase A2 to physio
logical and pathological conditions requires greater insight into thei
r cellular regulation and the development of selective inhibitors.